The $840 billion startup’s wildly successful partnership with Microsoft contains a prenuptial agreement triggered when ...
Eli Lilly and Company (NYSE: LLY) today announced positive, topline results from the Phase 3 ADorable-1 trial evaluating the safety and efficacy of EBGLYSS (lebrikizumab-lbkz) in pediatric patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results